Latest Medical Cannabis News

Page 3 of 3

Bioxyne Boosts FY25 Revenue Guidance to $25M on Record Half-Year Growth

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

Victor Sage

23 Jan 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026

Top